CureVac N.V. (CVAC)

NASDAQ: CVAC · IEX Real-Time Price · USD

3.340

+0.010 (0.30%)

At close: Jul 2, 2024, 4:00 PM

3.260

-0.080 (-2.40%)

After-hours: Jul 2, 2024, 7:57 PM EDT

CureVac Cash Flow Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Net Income	-260.17	-249.03	-411.72	-129.12	-99.87	Upgrade
Depreciation & Amortization	23.39	23.74	15.67	10.67	7.16	Upgrade
Share-Based Compensation	7.7	9.19	14.96	14.24	19.56	Upgrade
Other Operating Activities	-38.8	-70.07	-352.04	626.61	-13.82	Upgrade
Operating Cash Flow	-267.89	-286.18	-733.13	522.4	-86.96	Upgrade
Capital Expenditures	-52.32	-88.02	-124.22	-36.33	-11.17	Upgrade
Acquisitions	0	-0.28	0	0	0	Upgrade
Change in Investments	0	0	0	-1.16	38.08	Upgrade
Other Investing Activities	-2.88	-5.2	-3.68	-7.78	1.27	Upgrade
Investing Cash Flow	-55.2	-93.5	-127.9	-45.27	28.18	Upgrade
Share Issuance / Repurchase	236.09	67.39	373.15	867.72	0	Upgrade
Debt Issued / Paid	-5.19	-4.22	-28.18	-47.88	67.98	Upgrade
Financing Cash Flow	230.89	63.17	344.96	819.83	67.98	Upgrade
Exchange Rate Effect	-1.15	0.84	4.94	-5.05	0.11	Upgrade
Net Cash Flow	-92.19	-316.5	-516.07	1,297	9.2	Upgrade
Free Cash Flow	-320.21	-374.2	-857.35	486.07	-98.14	Upgrade
Free Cash Flow Margin	-595.65%	-555.03%	-832.46%	994.61%	-563.48%	Upgrade
Free Cash Flow Per Share	-1.43	-1.97	-4.58	2.75	-0.56	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).